Clinical Trials Logo

Shock, Septic clinical trials

View clinical trials related to Shock, Septic.

Filter by:

NCT ID: NCT02612363 Recruiting - Septic Shock Clinical Trials

Early Goal Directed Sedation on Microcirculation in Septic Shock

Start date: November 2015
Phase: Phase 4
Study type: Interventional

The investigators will conduct a prospective, single-center, randomized, double-blinded, controlled study to investigate the effect of early goal directed sedation on microcirculation in early septic shock patients.

NCT ID: NCT02612181 Recruiting - Septic Shock Clinical Trials

Dex on Microcirculation in SS—A Double-blinded Study

Start date: January 2016
Phase: Phase 4
Study type: Interventional

The investigators preliminary study showed that dexmedetomidine might improve microcirculation in septic shock patients. To test this effect, the investigators will conduct double-blinded study.

NCT ID: NCT02580240 Recruiting - Septic Shock Clinical Trials

Administration of Hydrocortisone for the Treatment of Septic Shock

Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study : 1)to determine whether hydrocortisone is effective in the treatment of septic shock and 2) to identify the role of timing of low dose hydrocortisone administration in septic shock patients.

NCT ID: NCT02565251 Recruiting - Sepsis Clinical Trials

Volemic Resuscitation in Sepsis and Septic Shock

Start date: September 2015
Phase: N/A
Study type: Interventional

Severe sepsis and septic shock are among the leading causes of morbidity and mortality in patients admitted in the ICU, being responsible for approximately 200000 deaths/year in the USA and 150000 in Europe. Recognizing the early signs of sepsis and the different stages of this condition may lower the associated morbidity and mortality. The hemodynamic profile of the septic shock is characterized by the presence of the distributive shock, on which we can add elements from the hypovolemic and cardiogenic shocks. The objecive of this study is to optimize the volemic resuscitation of the severe septic and of the septic shock patient using two minimally invasive methods of hemdynamic monitoring which both use the same device (Edwards Lifescience). In the same time hemodinamic data will be colected by mesuring the inferior vena cava diameter.

NCT ID: NCT02508350 Recruiting - Septic Shock Clinical Trials

The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock

Start date: January 2015
Phase: N/A
Study type: Interventional

The first objective of this study was to characterize the pharmacokinetics and pharmacodynamics of daptomycin with a daily dose of 12mg/kg in septic shock patient; the second objective is to identify the optimal dosing scheme for daptomycin among patients with septic shock and to enhance therapeutic outcomes.

NCT ID: NCT02391792 Recruiting - Clinical trials for Severe Sepsis and Septic Shock

Membrane Shedding During Severe Sepsis and Septic Shock: Pathophysiological and Clinical Relevance

Start date: March 2013
Phase: N/A
Study type: Observational [Patient Registry]

Microparticules (MPs) result from plasma cell membrane remodeling and shedding after cell stimulation or apoptosis. MPs are know recognized as a pool of bioactive messengers with merging role in pathophysiology of immune and cardiovascular diseases. MPs have been characterized during septic shock and may contribute to dissemination of pro-inflammatory and procoagulant mediators. This a prospective observational study of circulating MPs and blood coagulation in septic shock patients admitted in medical intensive care units (ICUs) of four tertiary hospitals at baseline (D1, D2, D3, D4, D7).

NCT ID: NCT02339649 Recruiting - Clinical trials for Severe Sepsis With Septic Shock

Long-term Cognitive and Cerebral Changes in Sepsis Survivors and Their Predictors

BonSEP
Start date: September 2013
Phase: N/A
Study type: Interventional

The main goals of this study are to provide a cognitive, neurological, brain morphological, and serological profile of sepsis survivors in order to make long-term prognosis of recovery and estimate the need for rehabilitation measures in order to help patients reintegrate into normal daily life.

NCT ID: NCT02306239 Recruiting - Septic Shock Clinical Trials

The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients

Start date: December 2014
Phase: N/A
Study type: Interventional

Terlipressin becomes a vasopressin for septic shock. But some studies found it may lead to severe intesitnal complications such as intestinal ischemia. The investigators study was designed to find the effect of terlipressin on intestinal function in septic shock patients.

NCT ID: NCT02150512 Recruiting - Septic Shock Clinical Trials

Resuscitation Strategies in Septic Shock

ReSSeS
Start date: November 2014
Phase: N/A
Study type: Interventional

The purpose of this study, in mechanically ventilated septic shock patients, is to determine whether a fluid loading strategy based on parameters derived from the transpulmonary thermodilution technique may lead to more ventilator free days compared to a fluid loading strategy based on the surviving sepsis guidelines.

NCT ID: NCT02135796 Recruiting - Septic Shock Clinical Trials

Echocardiography in Septic Shock

Start date: October 2008
Phase:
Study type: Observational

BACKGROUND: Echocardiography can provide evaluation of right or left ventricular dysfunction and volume status during resuscitation of patients with sepsis and septic shock and guide intravenous vasopressor and fluid therapy. While there are numerous echocardiographic studies regarding cardiac function and volume status in patients with established shock, there are none that describe these during the early resuscitation of septic shock. The study objective is to correlate echocardiographic findings with clinical parameters and net fluid balance measured during the early resuscitation of critically ill patients with sepsis and septic shock. Aim 1) correlate echocardiographic findings of cardiac function with physiologic markers in the early hours of resuscitation Aim 2) correlate cardiac function and fluid status with clinical outcomes Aim 3) evaluate the change in cardiac function over time in patients with sepsis and septic shock Aim 4) evaluate long term clinical outcomes for patients with sepsis and septic shock.